Last reviewed · How we verify
diosmetin
diosmetin is a diosmetin drug. It is currently FDA-approved.
Diosmetin is a small molecule compound that can be found in the Caucasian vetch. It is an O-methylated flavone, specifically 5,7,3′-trihydroxy-4′-methoxyflavone.
At a glance
| Generic name | diosmetin |
|---|---|
| Drug class | diosmetin |
| Target | Inositol hexakisphosphate kinase 2, Inositol polyphosphate multikinase, Cytochrome P450 1B1 |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- diosmetin CI brief — competitive landscape report
- diosmetin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about diosmetin
What is diosmetin?
diosmetin is a diosmetin drug.
What drug class is diosmetin in?
diosmetin belongs to the diosmetin class. See all diosmetin drugs at /class/diosmetin.
What development phase is diosmetin in?
diosmetin is FDA-approved (marketed).
What does diosmetin target?
diosmetin targets Inositol hexakisphosphate kinase 2, Inositol polyphosphate multikinase, Cytochrome P450 1B1 and is a diosmetin.
Related
- Drug class: All diosmetin drugs
- Target: All drugs targeting Inositol hexakisphosphate kinase 2, Inositol polyphosphate multikinase, Cytochrome P450 1B1
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing